Virally Induced Inflammation Triggers Fratricide of Fas-Ligand–Expressing β-Cells
- Urs Christen1,
- Rima Darwiche2,
- Helen E. Thomas2,
- Tom Wolfe1,
- Evelyn Rodrigo1,
- Alexander Chervonsky3,
- Richard A. Flavell3 and
- Matthias G. von Herrath1
- 1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California
- 2St. Vincent’s Institute, Fitzroy, Victoria, Australia
- 3Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut
- Address correspondence and reprint requests to Matthias G. von Herrath, MD, Division of Developmental Immunology, DI-3, La Jolla Institute for Allergy and Immunology, 10355 Science Center Dr., San Diego, CA 92121. E-mail: matthias{at}liai.org
Abstract
Tissue-specific expression of Fas-ligand (Fas-L) can provide immune privilege by inducing apoptosis of “invading” lymphocytes expressing Fas. However, accelerated diabetes has been reported in transgenic mice expressing Fas-L in islets (RIP-Fas-L) as a result of Fas-dependent fratricide of β-cells after transfer of diabetogenic clones. Here we studied whether Fas-L could protect islets from autoaggressive CD8 lymphocytes in a transgenic model of virally induced diabetes (RIP-LCMV-NP transgenic mice), in which the autoaggressive response is directed to a viral nucleoprotein (NP) expressed as a transgene in β-cells. Indeed, disease incidence after viral (lymphocytic choriomeningitis virus [LCMV]) infection was reduced by ∼30%, which was associated with a decrease of autoaggressive CD8 NP-specific lymphocytes in islets and pancreatic draining lymph nodes. However, surprisingly, a high degree (50%) of diabetes was seen in mice that expressed only Fas-L but not the viral transgene (NP) in β-cells after infection with LCMV. This was due to induction of Fas on β-cells after LCMV infection of the pancreas, resulting in Fas/Fas-L–mediated fratricide. Thus, although Fas-L can lend some immune privilege to islet cells, local virus-induced inflammation will induce Fas on β-cells, leading to their mutual destruction if Fas-L is present. Expression of Fas-L therefore might not be protective in situations in which viral inflammation can be expected, resulting in Fas induction on the targeted cell itself.
- CTL, cytotoxic T-cell
- Fas-L, Fas-ligand
- IFN-γ, γ-interferon
- LCMV, lymphocytic choriomeningitis virus
- mAb, monoclonal antibody
- NP, nucleoprotein
- RPA, RNase protection assay
Footnotes
-
- Accepted November 26, 2003.
- Received July 30, 2003.
- DIABETES














